Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Regulatory News & FDA Approvals » EliTech SARS-CoV-2, Influenza, RSV Multiplex Test Receives CE Mark

EliTech SARS-CoV-2, Influenza, RSV Multiplex Test Receives CE Mark

Dec 15, 2020
|
staff reporter

NEW YORK – EliTech Group announced Tuesday its SARS-CoV-2 Plus Elite MGB Kit received CE marking and has been launched.

The kit detects and distinguishes between SARS-CoV-2, influenza A/B, and respiratory syncytial virus types A and B, the company said in a statement. It runs on the firm's Elite InGenius platform, as well as other major PCR thermocyclers. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Lander Nominated for Science Advisor

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.

What's It Called?

Nature News writes that scientists are trying to figure out how to name the new strains of SARS-CoV-2 that are emerging.

Twin COVID-19 Studies

The New York Times reports that researchers are studying identical twins who had COVID-19 to understand the influence of genetics on disease severity.

PNAS Papers on Positive Epistasis in Cystic Fibrosis, Tiger Rattlesnake Genome, More

In PNAS this week: epistasis affecting cystic fibrosis, Tiger rattlesnake genome gives venom insight, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. MiRxes Receives CE Mark, Singapore Regulatory Approval for Multiplex SARS-CoV-2, Flu Test

  2. FDA Grants Emergency Use Authorization for SML Genetree Molecular Coronavirus Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.